jbrown33	10.1200/JCO.2016.34.15_suppl.TPS2594	<http://dx.doi.org/10.1200/jco.2016.34.15_suppl.tps2594>; rel="canonical"	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:j.0="http://purl.org/dc/terms/" xmlns:j.1="http://prismstandard.org/namespaces/basic/2.1/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:j.2="http://purl.org/ontology/bibo/" xmlns:j.3="http://xmlns.com/foaf/0.1/"><rdf:Description rdf:about="http://dx.doi.org/10.1200/JCO.2016.34.15_suppl.TPS2594"><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/alison-l-hannah-3l1fegl2fv4fu"><j.3:name>Alison L. Hannah</j.3:name><j.3:familyName>Hannah</j.3:familyName><j.3:givenName>Alison L.</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/sarah-slater-3l1fegl2fv4fu"><j.3:name>Sarah Slater</j.3:name><j.3:familyName>Slater</j.3:familyName><j.3:givenName>Sarah</j.3:givenName></j.3:Person></j.0:creator><j.1:volume>34</j.1:volume><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/juanita-lopez-3l1fegl2fv4fu"><j.3:name>Juanita Lopez</j.3:name><j.3:familyName>Lopez</j.3:familyName><j.3:givenName>Juanita</j.3:givenName></j.3:Person></j.0:creator><j.2:pageStart>TPS2594</j.2:pageStart><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/rebecca-sophie-kristeleit-3l1fegl2fv4fu"><j.3:name>Rebecca Sophie Kristeleit</j.3:name><j.3:familyName>Kristeleit</j.3:familyName><j.3:givenName>Rebecca Sophie</j.3:givenName></j.3:Person></j.0:creator><j.2:volume>34</j.2:volume><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/marc-frederick-engelhardt-3l1fegl2fv4fu"><j.3:name>Marc Frederick Engelhardt</j.3:name><j.3:familyName>Engelhardt</j.3:familyName><j.3:givenName>Marc Frederick</j.3:givenName></j.3:Person></j.0:creator><j.1:doi>10.1200/jco.2016.34.15_suppl.tps2594</j.1:doi><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/martina-maurer-3l1fegl2fv4fu"><j.3:name>Martina Maurer</j.3:name><j.3:familyName>Maurer</j.3:familyName><j.3:givenName>Martina</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/anne-schmitt-hoffmann-3l1fegl2fv4fu"><j.3:name>Anne Schmitt-Hoffmann</j.3:name><j.3:familyName>Schmitt-Hoffmann</j.3:familyName><j.3:givenName>Anne</j.3:givenName></j.3:Person></j.0:creator><owl:sameAs rdf:resource="http://dx.doi.org/10.1200/jco.2016.34.15_suppl.tps2594"/><j.0:identifier>10.1200/jco.2016.34.15_suppl.tps2594</j.0:identifier><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/t-r-jeffry-evans-3l1fegl2fv4fu"><j.3:name>T.R. Jeffry Evans</j.3:name><j.3:familyName>Evans</j.3:familyName><j.3:givenName>T.R. Jeffry</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/jessica-brown-3l1fegl2fv4fu"><j.3:name>Jessica Brown</j.3:name><j.3:familyName>Brown</j.3:familyName><j.3:givenName>Jessica</j.3:givenName></j.3:Person></j.0:creator><j.1:startingPage>TPS2594</j.1:startingPage><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/stephanie-anderson-3l1fegl2fv4fu"><j.3:name>Stephanie Anderson</j.3:name><j.3:familyName>Anderson</j.3:familyName><j.3:givenName>Stephanie</j.3:givenName></j.3:Person></j.0:creator><j.0:date rdf:datatype="http://www.w3.org/2001/XMLSchema#date" >2016-05-20</j.0:date><j.0:publisher>American Society of Clinical Oncology (ASCO)</j.0:publisher><j.1:endingPage>TPS2594</j.1:endingPage><j.2:pageEnd>TPS2594</j.2:pageEnd><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/felix-bachmann-3l1fegl2fv4fu"><j.3:name>Felix Bachmann</j.3:name><j.3:familyName>Bachmann</j.3:familyName><j.3:givenName>Felix</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/elizabeth-r-plummer-3l1fegl2fv4fu"><j.3:name>Elizabeth R. Plummer</j.3:name><j.3:familyName>Plummer</j.3:familyName><j.3:givenName>Elizabeth R.</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/yvette-drew-3l1fegl2fv4fu"><j.3:name>Yvette Drew</j.3:name><j.3:familyName>Drew</j.3:familyName><j.3:givenName>Yvette</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/sola-adeleke-3l1fegl2fv4fu"><j.3:name>Sola Adeleke</j.3:name><j.3:familyName>Adeleke</j.3:familyName><j.3:givenName>Sola</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/nikolaos-diamantis-3l1fegl2fv4fu"><j.3:name>Nikolaos Diamantis</j.3:name><j.3:familyName>Diamantis</j.3:familyName><j.3:givenName>Nikolaos</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/manolo-darcangelo-3l1fegl2fv4fu"><j.3:name>Manolo D'Arcangelo</j.3:name><j.3:familyName>D'Arcangelo</j.3:familyName><j.3:givenName>Manolo</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/donna-crawford-3l1fegl2fv4fu"><j.3:name>Donna Crawford</j.3:name><j.3:familyName>Crawford</j.3:familyName><j.3:givenName>Donna</j.3:givenName></j.3:Person></j.0:creator><j.0:isPartOf><j.2:Journal rdf:about="http://id.crossref.org/issn/0732-183X"><j.1:issn>1527-7755</j.1:issn><j.2:issn>1527-7755</j.2:issn><owl:sameAs>urn:issn:1527-7755</owl:sameAs><owl:sameAs>urn:issn:0732-183X</owl:sameAs><j.0:title>Journal of Clinical Oncology</j.0:title><j.1:issn>0732-183X</j.1:issn><j.2:issn>0732-183X</j.2:issn></j.2:Journal></j.0:isPartOf><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/paul-gougis-3l1fegl2fv4fu"><j.3:name>Paul Gougis</j.3:name><j.3:familyName>Gougis</j.3:familyName><j.3:givenName>Paul</j.3:givenName></j.3:Person></j.0:creator><j.2:doi>10.1200/jco.2016.34.15_suppl.tps2594</j.2:doi><owl:sameAs rdf:resource="doi:10.1200/jco.2016.34.15_suppl.tps2594"/><j.0:title>A Phase 1 study to assess the safety, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activities of daily oral BAL101553, a novel tumor checkpoint controller (TCC) in adult patients with advanced solid tumors.</j.0:title><owl:sameAs rdf:resource="info:doi/10.1200/jco.2016.34.15_suppl.tps2594"/><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/heidi-a-lane-3l1fegl2fv4fu"><j.3:name>Heidi A Lane</j.3:name><j.3:familyName>Lane</j.3:familyName><j.3:givenName>Heidi A</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/alexandar-tzankov-3l1fegl2fv4fu"><j.3:name>Alexandar Tzankov</j.3:name><j.3:familyName>Tzankov</j.3:familyName><j.3:givenName>Alexandar</j.3:givenName></j.3:Person></j.0:creator></rdf:Description></rdf:RDF>
